📰 Refinitiv Eikon News
Page 34 - Refinitiv Eikon News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Refinitiv Eikon. Real-time updates on events, politics, business and more.
April 28, 2023
LONDON/BEIJING/HANOI (Reuters) - Lithium prices rebounded this week for the first time in five months after tumbling from record highs, but new supply of the key mineral for electric vehicle (EV) batteries coming on stream is likely to weigh on the market next year. | 02:02pm
April 28, 2023
By Arathy Somasekhar and Marianna Parraga HOUSTON, April 28 (Reuters) – Chevron Corp has stepped up sales of Venezuelan crude oil to rival U.S. refiners, adding PBF Energy Inc and Marathon Petroleum Corp to its list...
April 28, 2023
A new supply is expected to weigh on the market next year
April 28, 2023
Lithium prices rebounded this week for the first time in five months after tumbling from record highs, but new supply of the key mineral for electric vehicle (EV) batteries coming on stream is likely to weigh on the market next year.
April 27, 2023
Venezuelas oil exports to Cuba this year dropped to 55,000bpd from almost 80,000 in 2020
April 27, 2023
Cuba increasingly is turning to Russia and México for oil to ease an acute shortage of diesel and gasoline and supplement dwindling supplies of Venezuelan crude and fuel, according to shipping data and sources.
April 26, 2023
German sportswear maker Puma on Wednesday said it expected second-quarter sales to grow at a low- to mid-single-digit percentage rate, below its full-year target, due to high inventory levels and ongoing challenges in the market.
April 26, 2023
Whitbread Plcs full-year profit beat expectations and the Premier Inn owner raised its annual dividend on Tuesday 25 April.
April 26, 2023
Cuba increasingly is turning to Russia and Mexico for oil to ease an acute shortage of diesel and gasoline and supplement dwindling supplies of Venezuelan crude and fuel, according to shipping data and sources.
April 25, 2023
By Ludwig Burger FRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings outlook following cost cuts, a breast cancer drug trial success and ...